Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
DBV Technologies has announced the filing of its Form 10-K with the U.S. Securities and Exchange Commission and its Universal Registration Document 20…
DBV Technologies has announced its inclusion in the CAC Mid 60 and SBF 120 indexes following the annual review of the Euronext Paris indexes. This cha…
DBV Technologies shares saw a slight increase of 0.14% this Tuesday, March 17, 2026, trading at €3.465, after experiencing significant selling pressur…
DBV Technologies marked a significant progression this Thursday, March 5, with a share price at 4.04 euros, up 7.59% from the previous day. The biotec…
DBV Technologies announces its participation in two investor conferences scheduled for March. The biopharmaceutical company will present its business …
DBV Technologies announces that it will present additional data from the phase 3 VITESSE study on the VIASKIN® Peanut patch in children aged 4 to 7 at…
DBV Technologies announces the participation of its CEO at a major conference organized by Guggenheim Securities. This presentation is part of the bio…
DBV Technologies shares rose by 4.26% this Wednesday midday, reaching 4.16 euros. The French biotech company, specializing in the treatment of food al…
DBV Technologies surged by 10.64% this Friday morning, moving from €3.81 to €4.21. This sharp rise is part of a marked acceleration over several weeks…
DBV Technologies has announced a gross proceeds of €166.7 million following the full exercise of warrants issued during its March 2025 financing round…